VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
Clinical trial NCT06092333 · RECRUITING
Trial details
- NCT number
- NCT06092333
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-31
- Primary completion
- 2028-02-29
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.